Paul Jansen

Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma

Dave Ricks, CEO of Eli Lilly, discusses the company's groundbreaking GLP-1 drugs, their potential beyond weight loss, the complexities of drug development and pricing, and how Eli Lilly is innovating in pharmaceutical research and direct-to-consumer healthcare.